Oral thin film drug is a promising drug delivery dosage form, which delivers drugs by adhering to the oral mucosa. Oral thin film drugs are a strip of multilayered or single layered, non-muco-adhesive or muco-adhesive, thin polymeric films that are intended to deliver active therapeutic moieties either systemically or locally in oral cavity through palatal, buccal, or sublingual absorption. These offer several advantages such as bypassing the hepatic first pass effect, fast onset of action, and ease of transportation. These films offer rapid absorption and high bioavailability for the drugs. Types of oral thin film drugs are fast disintegrating buccal film, melt away film, and non-disintegrating buccal film. An ultra-thin film quickly dissolves on the buccal cavity or tongue or on the top of the tongue. This is prepared using hydrophilic polymers that have fast dissolving property.
Oral thin film drugs are kept on a patient’s oral mucosal tissue or tongue, which gets wet by saliva and quickly hydrates and adheres on the site of application. This disintegrates within a few seconds to promote oromucosal absorption. Increase in inclination toward non-invasive or minimally invasive treatment drives demand for oral thin film drugs. These drugs offer high therapeutic index with good physical properties such as faster disintegration and dissolution. Moreover, the oral thin film drug delivery system allows to bypass the first pass metabolism and ensures higher bioavailability. Demand for oral thin film drugs has been increasing across the world owing to technological advancements in these products. These drugs have experienced significant market acceptance due to high effectiveness and ease of application. However, high cost of treatment can impact market adoption of these drugs.
The global oral thin film drugs market can be segmented based on product type, disease type, distribution channel, and region. In terms of product type, the market can be divided into fully dissolving dental or buccal film, and sublingual film. Based on disease type, the global oral thin film drugs market can be classified into schizophrenia, migraine, opioid dependence, nausea & vomiting, and others. In terms of distribution channel, the market can be categorized into online pharmacies, retail pharmacies, and hospital pharmacies.
Geographically, the global oral thin film drugs market can be segmented into Latin America, Europe, North America, Middle East & Africa, and Asia Pacific. North America held large market share in 2016 owing to high market acceptance of innovative drug delivery systems and better therapeutic outcome of the oral dosage form. Europe held the second largest market share due to strong product pipeline, significant research activities, and high market adoption of oral thin film drug delivery. The market in Asia Pacific is anticipated to be driven during the forecast period by continuous introduction of new technology. The global oral thin film drugs market in Middle East & Africa and Latin America is expected to witness significant growth during the forecast period due to major pharmaceutical players are focusing their efforts toward providing services to the large and growing populations in countries in the Middle East and developing countries in Latin America.
Key players in the global oral thin film drugs market include ZIM Laboratories Limited, Indivior plc, MonoSol Rx, Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., and Pfizer, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.